Since PTX3 is more sensitive than hs-CRP in distinguishing stages of DN, it holds promise as a more reliable biomarker for assessing kidney function and predicting the risk of chronic kidney disease (CKD) in diabetic patients [56]. This evidence concerns the gene PTX3 and liver dysplastic nodule.